Skip to content

Neoadjuvant chemoradiotheraphy in patients with locally advanced gastric cancer

Clinical trial to evaluate the resectability rate and tumor response to neoadjuvant chemo radiotherapy in patients with locally advanced proximal gastric cancer and esophagogastric cancer.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014072015044N1
Enrollment
30
Registered
2014-07-20
Start date
2012-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Proximal gastric cancer. Condition 2: Gastro-oesophageal cancer. Fundus of stomach Gastro-oesophagea cancerl

Interventions

All patients with locally advanced proximal gastric cancer and junction esophagogastric cancer receive Preoperative Chemoradiation therapy before surgery are candidates with a positive biopsy . Before
Treatment - Other

Sponsors

Vice chancellor for research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The main inclusion criteria: All patients with locally advanced proximal gastric cancer and esophagogastric cancer who have positive biopsy results and has been filled the consent form informally. The main exclusion criteria: patients (illness) at stage I and IV; patient dissatisfaction; comorbid diseases that prevent oncologic treatment; previous cancer; previous chemotherapy or radiotherapy; hepatic and renal dysfunction that prevents oncologic treatments; Performance status 3,4 ECOG

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Evaluation of resectability rate and tumor response in patients with locally advanced proximal gastric cancer and esophagogastric cancer treated with neoadjuvant chemoradiotheraphy. Timepoint: Pathologic Evaluation of surgical specimen. Method of measurement: Pathologic response.

Secondary

MeasureTime frame
Rate of surgical copmplication. Timepoint: Post operation. Method of measurement: Incisional leek,post op mortality.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Emadi Torghabeh

Omid Hospital

emadita1@mums.ac.ir+98 51 1846 1518

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026